{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,9,9]],"date-time":"2023-09-09T17:18:56Z","timestamp":1694279936142},"reference-count":40,"publisher":"Public Library of Science (PLoS)","issue":"11","license":[{"start":{"date-parts":[[2015,11,10]],"date-time":"2015-11-10T00:00:00Z","timestamp":1447113600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0142873","type":"journal-article","created":{"date-parts":[[2015,11,10]],"date-time":"2015-11-10T18:58:18Z","timestamp":1447181898000},"page":"e0142873","update-policy":"http:\/\/dx.doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":11,"title":["Time to ART Initiation among Patients Treated for Rifampicin-Resistant Tuberculosis in Khayelitsha, South Africa: Impact on Mortality and Treatment Success"],"prefix":"10.1371","volume":"10","author":[{"given":"Johnny Flippie","family":"Daniels","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammed","family":"Khogali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erika","family":"Mohr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vivian","family":"Cox","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sizulu","family":"Moyo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary","family":"Edginton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sven Gudmund","family":"Hinderaker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Graeme","family":"Meintjes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer","family":"Hughes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Virginia","family":"De Azevedo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gilles","family":"van Cutsem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helen Suzanne","family":"Cox","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2015,11,10]]},"reference":[{"key":"ref1","unstructured":"World Health Organization. Global Tuberculosis Report 2014. WHO\/HTM\/TB\/2014.08. 2014."},{"key":"ref2","unstructured":"Shisana O, Rehle T, Simbayi L, Zuma K, Jooste S, Zungu N, et al. South African national HIV Prevalence, Incidence and Behaviour survey. Communication. Cape Town; 2014."},{"key":"ref3","doi-asserted-by":"crossref","first-page":"416","DOI":"10.3201\/eid1903.120998","article-title":"Treatment Outcomes for Extensively Drug-Resistant Tuberculosis and HIV Co-infection","volume":"19","author":"MR O\u2019Donnell","year":"2013","journal-title":"Emerg Infect Dis"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"e20436","DOI":"10.1371\/journal.pone.0020436","article-title":"Outcomes of Multi-Drug Resistant Tuberculosis (MDR-TB) among a Cohort of South African Patients with High HIV Prevalence","volume":"6","author":"JE Farley","year":"2011","journal-title":"PLoS One"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1164\/rccm.200907-0989OC","article-title":"HIV coinfection in multidrug- and extensively drug-resistant tuberculosis results in high early mortality","volume":"181","author":"NR Gandhi","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"441","DOI":"10.5588\/ijtld.13.0742","article-title":"Community-based treatment of drug-resistant tuberculosis in Khayelitsha, South Africa","volume":"18","author":"H Cox","year":"2014","journal-title":"Int J Tuberc Lung Dis"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"e46943","DOI":"10.1371\/journal.pone.0046943","article-title":"Outcomes of Multidrug-Resistant Tuberculosis Treatment with Early Initiation of Antiretroviral Therapy for HIV Co-Infected Patients in Lesotho","volume":"7","author":"H Sattie","year":"2012","journal-title":"PLoS One"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"147","DOI":"10.5588\/ijtld.13.0627","article-title":"Improved survival in multidrug-resistant tuberculosis patients receiving integrated tuberculosis and antiretroviral treatment in the SAPiT Trial","volume":"18","author":"N Padayatchi","year":"2014","journal-title":"Int J Tuberc Lung Dis"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1016\/S0140-6736(10)60492-8","article-title":"Early treatment outcomes and HIV status of patients with extensively drug-resistant tuberculosis in South Africa: a retrospective cohort study","volume":"375","author":"K Dheda","year":"2010","journal-title":"Lancet"},{"key":"ref10","first-page":"1382","article-title":"Adverse events in the treatment of multidrug-resistant tuberculosis: results from the DOTS-Plus initiative","volume":"8","author":"E Nathanson","year":"2008","journal-title":"Int J Tuberc Lung Dis"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"e40781","DOI":"10.1371\/journal.pone.0040781","article-title":"Adverse events among HIV\/MDR-TB co-infected patients receiving antiretroviral and second line anti-TB treatment in Mumbai, India","volume":"7","author":"P Isaakidis","year":"2012","journal-title":"PLoS One"},{"key":"ref12","unstructured":"World Health Organization. Companion handbook to the WHO guidelines for the programmatic management of drug-resistant tuberculosis. WHO\/HTM\/TB\/2014.11. Geneva, Switzerland; 2014."},{"key":"ref13","article-title":"Timing of Initiation of Antiretroviral Drugs during Tuberculosis Therapy","author":"SS Abdool Karim","year":"2010","journal-title":"N Engl J Med"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1056\/NEJMoa1013607","article-title":"Timing of antiretroviral therapy for HIV-1 infection and tuberculosis","volume":"365","author":"DV Havlir","year":"2011","journal-title":"N Engl J Med"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1056\/NEJMoa1013911","article-title":"Earlier versus later start of antiretroviral therapy in HIV-infected adults with tuberculosis","volume":"365","author":"FX Blanc","year":"2011","journal-title":"N Engl J Med"},{"key":"ref16","unstructured":"National Department of Health, South Africa. Management of Drug-Resistant Tuberculosis Policy Guidelines (updated January 2013) [Internet]. Available: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.health-e.org.za\/wp-content\/uploads\/2014\/06\/MDR-TB-Clinical-Guidelines-Updated-Jan-2013.pdf\" xlink:type=\"simple\">http:\/\/www.health-e.org.za\/wp-content\/uploads\/2014\/06\/MDR-TB-Clinical-Guidelines-Updated-Jan-2013.pdf<\/ext-link>"},{"key":"ref17","unstructured":"National Department of Health, South Africa. The South Africa antiretroviral treatment guidelines 2013 [Internet]. Available: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.auruminstitute.org\/phocadownload\/guidelines-short.pdf\" xlink:type=\"simple\">http:\/\/www.auruminstitute.org\/phocadownload\/guidelines-short.pdf<\/ext-link>"},{"key":"ref18","unstructured":"Medecins Sans Frontieres Khayelitsha 2001\u20132011, Activity Report: 10 years of HIV\/TB care at primary health care level. 2011;"},{"key":"ref19","unstructured":"Western Cape Department of Health. Western Cape antenatal HIV survey 2010. 2010."},{"key":"ref20","unstructured":"Strategic Development Information and GIS Department CoCT. City of Cape Town\u20142011 Census\u2014Khayelitsha Health District. 2013 [Internet]. Available: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.capetown.gov.za\/en\/stats\/2011CensusSuburbs\/2011_Census_CT_Suburb_Khayelitsha_Profile.pdf\" xlink:type=\"simple\">http:\/\/www.capetown.gov.za\/en\/stats\/2011CensusSuburbs\/2011_Census_CT_Suburb_Khayelitsha_Profile.pdf<\/ext-link>"},{"key":"ref21","unstructured":"Southern African HIV Clinicians Society. Antiretroviral therapy in adults: guidelines. South Afr J HIV Med. 2008; Available: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.sahivsoc.org\/upload\/documents\/guidelines_Guidelines_for_Antiretroviral_Therapy_in_Adults.pdf\" xlink:type=\"simple\">http:\/\/www.sahivsoc.org\/upload\/documents\/guidelines_Guidelines_for_Antiretroviral_Therapy_in_Adults.pdf<\/ext-link>"},{"key":"ref22","unstructured":"National Department of Health, South Africa. Management of Drug-Resistant TB in South Africa: draft policy guidelines. 2009."},{"key":"ref23","unstructured":"National Department of Health, South Africa. National Tuberculosis Management Guidelines, 2009. 2009."},{"key":"ref24","unstructured":"National Department of Health, South Africa. The South African Antiretroviral Treatment Guidelines 2010 [Internet]. Available: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.google.com\/url?sa=t&rct=j&q=&esrc=s&source=web&cd=1&ved=0CCQQFjAA&url=http:\/\/www.genderjustice.org.za\/resources\/doc_download\/502-south-african-antiretroviral-treatment-guidelines-2010.html&ei=xRs8U9i0IYev7AbAt4HYCA&usg=AFQjCNGHfPJ201vy23q0SrsSX\" xlink:type=\"simple\">http:\/\/www.google.com\/url?sa=t&amp;rct=j&amp;q=&amp;esrc=s&amp;source=web&amp;cd=1&amp;ved=0CCQQFjAA&amp;url=http:\/\/www.genderjustice.org.za\/resources\/doc_download\/502-south-african-antiretroviral-treatment-guidelines-2010.html&amp;ei=xRs8U9i0IYev7AbAt4HYCA&amp;usg=AFQjCNGHfPJ201vy23q0SrsSX<\/ext-link>"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"114","DOI":"10.4102\/sajhivmed.v13i3.125","article-title":"Guidelines for antiretroviral therapy in adults","volume":"13","year":"2012","journal-title":"South Afr J HIV Med"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"867","DOI":"10.2471\/BLT.07.045120","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: guidelines for reporting observational studies","volume":"85","author":"E Von Elm","year":"2007","journal-title":"Bull World Health Organ"},{"key":"ref27","unstructured":"World Health Organization. Guidelines for the programmatic management of drug-resistant tuberculosis: 2011 update. Geneva, Switzerland; 2011."},{"key":"ref28","unstructured":"National Department of Health, South Africa. Management of Drug-Resistant tuberculosis policy guidelines, August 2011 [Internet]. Available: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.gov.za\/documents\/download.php?f=165278\" xlink:type=\"simple\">http:\/\/www.gov.za\/documents\/download.php?f=165278<\/ext-link>"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"S238","DOI":"10.1086\/651497","article-title":"Integration of tuberculosis and HIV services in sub-Saharan Africa: lessons learned","volume":"50","author":"AA Howard","year":"2010","journal-title":"Clin Infect Dis"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"e46988","DOI":"10.1371\/journal.pone.0046988","article-title":"The effect of complete integration of HIV and TB services on time to initiation of antiretroviral therapy: a before-after study","volume":"7","author":"B Kerschberger","year":"2012","journal-title":"PLoS One"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/S1473-3099(08)70184-1","article-title":"Tuberculosis-associated immune reconstitution inflammatory syndrome: case definitions for use in resource-limited settings","volume":"8","author":"G Meintjes","year":"2008","journal-title":"Lancet Infect Dis"},{"key":"ref32","first-page":"410","article-title":". A practical approach to the diagnosis and management of paradoxical tuberculosis immune reconstitution inflammatory syndrome: TB-associated immune reconstitution inflammatory syndrome is seen after the initiation of antiretroviral therapy","volume":"29","author":"G Meintjes","year":"2011","journal-title":"CME"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"32","DOI":"10.7326\/M14-2979","article-title":"Optimal Timing of Antiretroviral Therapy Initiation for HIV-Infected Adults With Newly Diagnosed Pulmonary Tuberculosis: A Systematic Review and Meta-analysis","volume":"163","author":"O Uthman","year":"2015","journal-title":"Ann Intern Med"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"969","DOI":"10.5588\/ijtld.15.0123","article-title":"Treatment outcomes for HIV and MDR-TB co-infected adults and children: systematic review and meta-analysis","volume":"19","author":"P Isaakidis","year":"2015","journal-title":"Int J Tuberc Lung Dis"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1093\/trstmh\/trv037","article-title":"Programmatic treatment outcomes in HIV-infected and uninfected drug-resistant tuberculosis patients in Khayelitsha, South Africa","volume":"109","author":"E Mohr","year":"2015","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1097\/QAD.0b013e32830007cd","article-title":"Early mortality among adults accessing antiretroviral treatment programmes in sub-Saharan Africa","author":"SD Lawn","year":"2008","journal-title":"AIDS (London, England)"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"e1001718","DOI":"10.1371\/journal.pmed.1001718","article-title":"Mortality in Patients with HIV-1 Infection Starting Antiretroviral Therapy in South Africa, Europe, or North America: A Collaborative Analysis of Prospective Studies","volume":"11","author":"A Boulle","year":"2014","journal-title":"Plos Med"},{"key":"ref38","first-page":"144","article-title":"Guidelines for antiretroviral therapy in adults","volume":"13","year":"2012","journal-title":"South Afr J HIV Med"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"121","DOI":"10.4102\/sajhivmed.v15i4.330","article-title":"Adult antiretroviral therapy guidelines, 2014","volume":"15","year":"2014","journal-title":"South Afr J HIV Med"},{"key":"ref40","unstructured":"National Department of Health, South Africa. National Tuberculosis Management Guidelines, 2014. 2014 [Internet]. Available: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.sahivsoc.org\/upload\/documents\/NTCP_Adult_TB\" xlink:type=\"simple\">http:\/\/www.sahivsoc.org\/upload\/documents\/NTCP_Adult_TB<\/ext-link> Guidelines 27.5.2014.pdf"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0142873","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T11:50:24Z","timestamp":1567338624000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0142873"}},"subtitle":[],"editor":[{"given":"Pierre","family":"Roques","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2015,11,10]]},"references-count":40,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2015,11,10]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0142873","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,11,10]]}}}